Docusate Sodium
- Product NDC
- 0121-0935
- 11-digit product format
- 001210935
- Labeler code
- 0121
- Product ID
- 0121-0935_5cfc4685-c885-4303-a988-5009cbd8e57b
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Docusate Sodium
- Dosage form
- LIQUID
- Route
- ORAL
- Labeler
- PAI Holdings, LLC dba PAI Pharma
- Application
- M007
- Marketing category
- OTC MONOGRAPH DRUG
- Marketing start
- 2021-08-16
- Substance
- DOCUSATE SODIUM
- Active strength
- 50 mg/5mL
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 0121-0935 | 0121-0935-16 | D | Discontinued by firm | 2026-11-19 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Archive | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 0121-0935 | 0121-0935-16 | D | Discontinued by firm | excluded / ndc_excluded.zip | d630ba8d3edf… | 732f749b63fb… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Docusate Sodium
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| DOCUSATE SODIUM | 50 mg/5mL |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| F05Q2T2JA0 | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 1245686 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| e975a3f1-0e1f-4fb8-9c5f-baa75e12f2a5 | Available on FDA.report |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0121-0935-05 | Docusate Sodium | 5 mL in 1 CUP, UNIT-DOSE | LIQUID | 5 | 9 | |
| 0121-0935-16 | Docusate Sodium | 473 mL in 1 BOTTLE | LIQUID | 473 | 9 | |
| 0121-0935-40 | Docusate Sodium | 10 in 1 TRAY | LIQUID | 10 | 9 | |
| 0121-0935-40 | Docusate Sodium | 4 in 1 CASE | LIQUID | 4 | 9 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0121-0935-05 | ML - Milliliter | 0121-0935 | bd4be1fb-4d63-4e7c-8bfa-2e34cd4de1c5 | 1 | 2021-10-08 |
| 0121-0935-16 | ML - Milliliter | 0121-0935 | 3bdd2684-e7df-4efc-abb2-b74bbcf7d516 | 1 | 2021-10-08 |
| 0121-0935-40 | ML - Milliliter | 0121-0935 | 3327600b-3340-46f6-b2a4-f6be1a4545bb | 1 | 2021-10-08 |
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Magnesium Citrate | MAGNESIUM CITRATE | Hy-Vee, Inc. | 45374a86-80a4-481c-e063-6294a90a381a | 2026-02-04 | Warnings, Adverse reactions | M007 |
| Epsom Salt | MAGNESIUM SULFATE | Hy-Vee, Inc. | 44592ee0-13dd-57b1-e063-6394a90ab402 | 2026-02-04 | Warnings, Adverse reactions | M007 |
| Epsom Salt | MAGNESIUM SULFATE | Sam's West, Inc | 6edb7688-0a64-4a7e-a0c0-9f75c96682fe | 2026-02-03 | Warnings | M007 |
| Stool Softener Laxative | DOCUSATE SODIUM | EQUATE (Wal-Mart Stores, Inc.) (see also WAL-MART INC) | cb2698b1-6c58-417f-ae86-74fbe3814626 | 2026-02-03 | Warnings | M007 |
| Castor Oil | CASTOR OIL | CVS Pharmacy, Inc. | f20de8f2-3637-4485-8b80-0a12fd5e651c | 2026-02-02 | Warnings, Adverse reactions | M007 |
| Magnesium Citrate | MAGNESIUM CITRATE | CVS Pharmacy, Inc. | 1dca8f4a-f544-4ae5-bb0a-8b671d4a488a | 2026-02-02 | Warnings, Adverse reactions | M007 |
| citroma | MAGNESIUM CITRATE | CVS Pharmacy, Inc. | 15a9996d-7391-41f8-ab15-27ee2a6a60e4 | 2026-02-02 | Warnings, Adverse reactions | M007 |
| citroma | MAGESIUM CITRATE | Rite Aid Corporation | e562bf42-b9e1-4ea8-b880-7bec4dd620b4 | 2026-01-30 | Warnings, Adverse reactions | M007 |
| SENNA-S | DOCUSATE SODIUM AND SENNOSIDES | Strategic Sourcing Services, LLC | 905bd658-a0af-4f20-be3d-00c54868a26c | 2026-01-29 | Warnings | M007 |
| Senna Laxative | SENNOSIDES | Strategic Sourcing Services LLC | 9248a907-a8bd-47d5-98a2-48534d6023d4 | 2026-01-29 | Warnings | M007 |
| Leader Castor Oil | CASTOR OIL | Cardinal Health, 110 dba Leader | 49e3a40a-b717-43f6-abed-473d7ed03c2e | 2026-01-29 | Warnings, Adverse reactions | M007 |
| Mineral Oil | MINERAL OIL | CARDINAL HEALTH 110, LLC. DBA LEADER | 803f444f-d136-4f06-9842-24a71a3d7d6b | 2026-01-29 | Warnings, Adverse reactions | M007 |
| Equate Ready-to-Use Enema Laxative | SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM AND SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM | WalMart | 04c7440e-5b25-4b63-9604-321298d51021 | 2026-01-29 | Warnings | M007 |
| Stool Softener Laxative | DOCUSATE SODIUM | Meijer Distribution Inc. | 81edf0d8-b6f3-4b3a-85db-0108160756b1 | 2026-01-28 | Warnings | M007 |
| Quality Choice Laxative | SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM AND SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM | Chain Drug Marketing Association | 1cac3b6b-155b-47bb-bb79-17c55d345736 | 2026-01-28 | Warnings | M007 |
| Docusate Sodium and Sennosides | DOCUSATE SODIUM AND SENNOSIDES | SOFTGEL HEALTHCARE PRIVATE LIMITED | 1ad73079-ebb3-dae7-e063-6294a90a0558 | 2026-01-28 | Warnings | M007 |
| DOCUSATE SODIUM 100MG | DOCUSATE SODIUM 100MG | Farmacias De Similares TX LLC | 44269b79-a5ad-f443-e063-6294a90a8473 | 2026-01-28 | Warnings | M007 |
| Docusate Sodium and Sennosides | DOCUSATE SODIUM AND SENNOSIDES | SOFTGEL HEALTHCARE PRIVATE LIMITED | 19830f9a-27b1-910d-e063-6294a90adace | 2026-01-27 | Warnings | M007 |
| Sennosides | SENNOSIDES | SOFTGEL HEALTHCARE PRIVATE LIMITED | 94936bd4-8bbf-6211-e053-2995a90a2138 | 2026-01-27 | M007 | |
| Sennosides | SENNOSIDES | Softgel Healthcare Pvt Ltd | 16582306-7321-6c7c-e063-6394a90a509e | 2026-01-27 | Warnings | M007 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 1245686 | docusate sodium 50 MG in 5 mL Oral Solution | PSN | e975a3f1-0e1f-4fb8-9c5f-baa75e12f2a5 | 9 |
| 1245686 | docusate sodium 10 MG/ML Oral Solution | SCD | e975a3f1-0e1f-4fb8-9c5f-baa75e12f2a5 | 9 |
| 1245686 | docusate sodium 10 MG per 1 ML Oral Solution | SY | e975a3f1-0e1f-4fb8-9c5f-baa75e12f2a5 | 9 |
| 1245686 | docusate sodium 100 MG per 10 ML Oral Solution | SY | e975a3f1-0e1f-4fb8-9c5f-baa75e12f2a5 | 9 |
| 1245686 | docusate sodium 150 MG per 15 ML Oral Solution | SY | e975a3f1-0e1f-4fb8-9c5f-baa75e12f2a5 | 9 |
| 1245686 | DOSS Sodium 10 MG/ML Oral Solution | SY | e975a3f1-0e1f-4fb8-9c5f-baa75e12f2a5 | 9 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 0121-0935-05 | 00121093505 | 5 mL in 1 CUP, UNIT-DOSE | 5 ml | Historical | ||||
| 0121-0935-16 | 00121093516 | 473 mL in 1 BOTTLE (0121-0935-16) | 473 ml | 2021-08-16 | 0000-00-00 | No | No | Current |
| 0121-0935-40 | 00121093540 | 4 TRAY in 1 CASE (0121-0935-40) / 10 CUP, UNIT-DOSE in 1 TRAY / 5 mL in 1 CUP, UNIT-DOSE (0121-0935-05) | 4 tray | 2021-08-16 | 0000-00-00 | No | No | Current |